BRWM
NTLA icon

B. Riley Wealth Management’s Intellia Therapeutics NTLA Stock Holding History

B. Riley Wealth Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,685
Closed -$351K – 496
2020
Q2 		$351K Buy
+16,685
New +$283K 0.04% 272

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

B. Riley Wealth Management's NTLA Position: Q3 2020 in Review

B. Riley Wealth Management sold out of Intellia Therapeutics (NTLA) in Q3 2020, closing a stake of 16,685 shares — an estimated $351K sold.

B. Riley Wealth Management first reported a position in NTLA in Q2 2020 and held it in 1 quarter. The position peaked at $351K in Q2 2020. 165 funds tracked by Wall St. Rank hold NTLA as of Q3 2020.

  • B. Riley Wealth Management reported no remaining Intellia Therapeutics position as of Q3 2020 after selling out during the quarter.
  • B. Riley Wealth Management sold 16,685 Intellia Therapeutics shares in Q3 2020, an estimated $351K.
  • B. Riley Wealth Management first reported a position in Intellia Therapeutics in Q2 2020 and held it in 1 quarter.
  • B. Riley Wealth Management's Intellia Therapeutics position peaked at $351K in Q2 2020.
  • 165 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2020.

Based on B. Riley Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.